Lv51
842 积分 2024-07-21 加入
Prevalence of liver fibrosis and steatotic liver disease in community-dwelling adults in China (the CHESS-LiverHealth project): cross-sectional baseline data from a prospective cohort study
3小时前
已完结
Allostatic load, unhealthy behaviors, and mortality risk among participants with and without metabolic dysfunction–associated steatotic liver disease
15天前
已完结
Allostatic load, unhealthy behaviors, and mortality risk among participants with and without metabolic dysfunction–associated steatotic liver disease
24天前
已完结
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium
5个月前
已关闭
Comparative Effectiveness of Infliximab vs Ustekinumab for Endoscopic and Transmural Remission in Biologic Naïve Crohn’s Disease
7个月前
已关闭
Long-term effectiveness and safety of ustekinumab in patients with Crohn's disease: real-world evidence
7个月前
已完结
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study
7个月前
已完结
Real‐world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort
8个月前
已完结
白细胞介素-23p19抑制剂精准治疗克罗恩病的前景：机制与临床证据
10个月前
已完结
皖公网安备34019202002308
